Clinical Trials Results - National Cancer Institute

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

In English \| En español
Search

NCI Home

Cancer Topics


	Clinical Trials Search Results

Page Options

E-Mail This Search

Clinical Trial Questions?

Get Help:

1-800-4-CANCER or

LiveHelp online chat

	Quick Links


	Help Using the NCI Clinical Trials Search Form Educational Materials About Clinical Trials About NCI's Cancer Clinical Trials Registry Dictionary of Cancer Terms NCI Drug Dictionary

View Content for:

Patients
Health Professionals

Display:

Title
Description with: Locations Eligibility
Full Trial Description
Custom

Results 1-25 of 105 for your search:

Drug:  CHOP regimen
Find trials that include:  Any drugs shown
Trial Status:  Closed

Hide Search Criteria

Show Search Criteria

Help with Results

Select All on Page Sort by: Show Results per Page

Phase II/III Randomized Study of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) With Versus Without Etoposide in Older Patients With Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin's Lymphoma

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 70 and over
Sponsor: Other
Protocol IDs: EORTC-20991, NCT00060385

Phase III Randomized Study of Standard Chemotherapy vs High-Dose Chemotherapy with Hematopoietic Rescue Using Purged vs Unpurged AuBM or PBSC in Adults with Poor-Risk Relapsed Follicular non-Hodgkin's Lymphoma (Summary Last Modified 03/98)

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 65
Sponsor:
Protocol IDs: MRC-ECUP, EU-93009

Phase III Randomized Study of Sequential Treatment with 3 Noncross-Resistant Chemotherapy Combinations or Standard Chemotherapy for Poor-Prognosis Intermediate Grade and Immunoblastic non-Hodgkin's Lymphoma: IDA/CDDP/ARA-C/MePRDL, IDA/VCR/BLEO/CTX/MePRDL, and IFF/DHAD/VP-16 vs Standard CHOP (Summary Last Modified 09/2000)

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 15
Sponsor: NCI
Protocol IDs: MDA-DM-94017, NCI-T94-0040D, NCT00002565, T94-0040

Phase III Randomized International Study of Reduction in Intensification of the LMB 89 Regimen for non-Hodgkin's Lymphoma: Reduced Doses of CTX for Intermediate-Risk Patients and Less Maintenance Therapy for Intermediate-Risk and High-Risk Patients

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 6 months to under 21
Sponsor: NCI
Protocol IDs: COG-C5961, CCG-5961, SFOP-LMB-96, CCLG-NHL-9600, EU-96048, NCT00002757

Phase III Randomized Study of Induction With the ALL-2 Regimen (Cytarabine and High-Dose Mitoxantrone Based) Versus the L-20 Regimen (Vincristine and Prednisone Based) in Adults With Acute Lymphoblastic Malignancy: The ALL-4 Protocol

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: MSKCC-96015A1, NCI-V96-0881, NCT00002766

Phase III Randomized Study of High-Dose Sequential Chemotherapy Followed by Peripheral Blood Stem Cell Transplantation vs Cyclophosphamide/Doxorubicin/Vincristine/Prednisone (CHOP) for Poor-Risk, Intermediate- and High-Grade Non-Hodgkin's Lymphoma (Summary Last Modified 02/1999)

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: E-2493, E2493

Phase III Randomized Study of CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) With or Without Rituximab in Older Patients With Diffuse Mixed, Diffuse Large, or Immunoblastic Large Cell Non-Hodgkin's Lymphoma

Phase: Phase III
Type: Treatment
Status: Completed
Age: 60 and over
Sponsor: NCI
Protocol IDs: ECOG-E4494, E4494, CLB-9793, SWOG-E4494, NCT00003150

Phase III Randomized Study of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Sequential High-Dose Chemotherapy With Autologous Peripheral Blood Stem Cell Transplantation in Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 60
Sponsor: Other
Protocol IDs: SWS-SAKK-38/97, EU-97037, NCT00003215

Phase III Randomized Study of High Dose Chemotherapy and Autologous Bone Marrow Transplantation as Initial Therapy for Poor Risk Intermediate and High Grade Adult Non-Hodgkin's Lymphoma (Summary Last Modified 05/2002)

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 to 65
Sponsor:
Protocol IDs: BNLI-LY02, EU-98039, NCT00003578

10.

Phase III Randomized Study of CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) With or Without Rituximab in Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma

Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: AMC-010, CPMC-IRB-9691, CWRU-AMC-1400, UCLA-9810029, NCT00003595

11.

Phase III Randomized Study of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) With or Without Rituximab in Patients with Newly Diagnosed, Previously Untreated, Aggressive B-Cell Non-Hodgkin's Lymphoma (Summary Last Modified 02/2001)

Phase: Phase III
Type: Treatment
Status: Closed
Age: 19 and over
Sponsor: NCI
Protocol IDs: UNMC-447-97, UCLA-HSPC-9812071, NCI-G99-1601, NCT00004112

12.

Phase III Randomized Study of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Rituximab in Patients With Relapsed Follicular Non-Hodgkin's Lymphoma

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-20981, ALLG-NHLLOW4, BNLI-EORTC-20981, HOVON-H039, CAN-NCIC-LY7, NORDIC-EORTC-20981, NCT00004179, LY7

13.

Phase III Randomized Study of Mitoxantrone, Cyclophosphamide, Etoposide, Vincristine, Bleomycin, and Prednisolone (PMitCEBO) Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone (CHOP) in Patients With Aggressive Non-Hodgkin's Lymphoma

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 59
Sponsor: Other
Protocol IDs: BNLI-CHOPVPMITCEBO-GOODRISK, EU-99052, NCT00005867

14.

Phase III Chemotherapy with BCOP (BCNU/CTX/VCR/PRED) vs CHOP (CTX/ADR/VCR/PRED) for non-Hodgkin's Lymphoma

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: SEG-77NHL317, SEG-77NHL0103

15.

Phase III Induction Chemotherapy with CTX/ADR/VCR/PRED vs ADR/VCR/PRED for non-Hodgkin's Lymphoma

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7204/7205, SWOG-7204/05

16.

Phase III Chemotherapy with CTX/ADR/PRED vs VCR/CTX/ADR/PRED vs VCR/L-PAM/CTX/PRED vs VCR/BCNU/ADR/PRED for Multiple Myeloma

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7418, MDAR-1

17.

Phase III Induction with CHOP-BLEO vs CHOP & BCG vs COP-BLEO and Maintenance with BCG for non-Hodgkin's Lymphoma

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7426/27

18.

Phase III Study of Radiotherapy with or without CHOP (CTX/ADR/VCR/PRED) Chemotherapy for non-Hodgkin's Lymphoma (Summary Last Modified 07/97)

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 65
Sponsor: NCI
Protocol IDs: SWOG-7433, MDAR-116

19.

Phase III Induction with VMCP plus VCAP or VBAP vs L-PAM/PRED and Maintenance with VMCP with or without Levamisole for Myeloma

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7704/7705, MDAR-204

20.

Phase III Chemotherapy with CAVP (CTX/ADR/VCR/PRED) vs CVP (CTX/VCR/PRED) for Disseminated non-Hodgkin's Lymphoma

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: UMCC-7312A

21.

Phase III Induction with ACOP (VCR/ADR/CTX/PRED), CNS Therapy, & Maintenance with ACOP/6-MP/MTX/HC for Childhood non-Hodgkin's Lymphoma (Summary last modified 04/97)

Phase: Phase III
Type: Treatment
Status: Completed
Age: under 21
Sponsor: NCI
Protocol IDs: POG-7905, MDAR-356

22.

Phase III CHOP vs CHOP plus LEV vs CHOP/LEV/BCG with or without LEV Maintenance for Stage III-IV non-Hodgkin's Lymphoma

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7713/14, SWOG-7714

23.

Phase III Induction with COPA vs COPA/BLEO & Consolidation with High-Dose MTX/CF vs MTX for Stage III/IV Diffuse Histiocytic and Lymphocytic Lympoma

Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 to 70
Sponsor: NCI
Protocol IDs: CLB-7851, CALGB-7851

24.

Phase III Clinical Management of Adults with Previously Untreated Stage I/II/III/IV non-Hodgkin's Lymphoma of Unfavorable Histology

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to physiologic 74
Sponsor:
Protocol IDs: NCI-D82-051-878

25.

Phase III MTX/PRED/VCR Induction, CNS Prophylaxis, CHOP Consolidation and 6-MP/MTX/VCR/PRED with or without ARA-C/CTX/MePRDL/ADR Maintenance for ALL

Phase: Phase III
Type: Treatment
Status: Closed
Age: over 15
Sponsor:
Protocol IDs: SEG-78ALL333

Select All on Page

Help with Results

A Service of the National Cancer Institute